Predictors for Intracranial Hemorrhage Following Intravenous Thrombolysis in Posterior Circulation Stroke
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
15-31921A
Ministerstvo Zdravotnictví Ceské Republiky (CZ) - International
17-29452A
Ministerstvo Zdravotnictví Ceské Republiky (CZ) - International
17-30101A
Ministerstvo Zdravotnictví Ceské Republiky (CZ) - International
PubMed
29333567
DOI
10.1007/s12975-018-0608-0
PII: 10.1007/s12975-018-0608-0
Knihovny.cz E-resources
- Keywords
- Intracranial hemorrhage, Intravenous thrombolysis, Ischemic stroke, Posterior circulation,
- MeSH
- Stroke etiology therapy MeSH
- Fibrinolytic Agents adverse effects MeSH
- Intracranial Hemorrhages chemically induced diagnosis MeSH
- Administration, Intravenous MeSH
- Brain Ischemia complications MeSH
- Middle Aged MeSH
- Humans MeSH
- Magnetic Resonance Angiography MeSH
- Magnetic Resonance Imaging MeSH
- Predictive Value of Tests MeSH
- Retrospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Tissue Plasminogen Activator adverse effects MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Fibrinolytic Agents MeSH
- Tissue Plasminogen Activator MeSH
Intravenous thrombolysis (IVT) is a standard treatment for anterior (ACS) and posterior circulation stroke (PCS). However, due to the low occurrence of PCS and of intracranial hemorrhage (ICH) in PCS, the knowledge about ICH predictors following IVT in PCS is sparse. Our aim was to identify predictors for ICH following IVT in PCS. The set consisted of 1281 consecutive ischemic stroke (IS) patients treated with IVT, out of which 158 (103 males; mean age 65.6 ± 12.3 years) had PCS. Collected data include baseline characteristics, common stroke risk factors, pre-medication, stroke severity, admission blood glucose level, blood pressure and treatment with intravenous antihypertensive therapy before and during IVT, occlusion of arteries, recanalization rate, time to treatment, and clinical outcome at day 90. Overall, 11 (7%) patients had ICH. Atrial fibrillation (p = 0.004), neurological deficit at time of treatment in the National Institutes of Health Stroke Scale (p = 0.016), decreased level of consciousness (p = 0.003), occlusion of basilar artery (p = 0.007), occlusion of PCA (p = 0.001), and additional endovascular therapy (p = 0.001) were identified by logistic regression analysis as significant predictors for ICH in PCS. Patients with ischemic lesion in the brainstem, occlusion of vertebral artery, or absence of basilar and posterior cerebral artery occlusion might be considered for treatment with IVT even in borderline cases. Those patients seem to have less frequently favorable outcomes without an increase in ICH rate. Time to IVT in PCS seems not to influence ICH risk or chances for favorable outcomes as significantly as it does in ACS.
See more in PubMed
Cerebrovasc Dis. 2003;16(4):311-37 PubMed
Neurocrit Care. 2015 Apr;22(2):229-33 PubMed
Arch Neurol. 2012 Mar;69(3):346-51 PubMed
Cerebrovasc Dis. 2010;29(6):597-604 PubMed
Medicine (Baltimore). 2016 Jun;95(24):e3848 PubMed
Neurology. 2004 May 25;62(10):1854-6 PubMed
Eur J Neurol. 2006 Jul;13(7):742-8 PubMed
BMJ. 1998 Apr 18;316(7139):1236-8 PubMed
J Neurol Sci. 2013 Dec 15;335(1-2):96-100 PubMed
Neurology. 1993 Aug;43(8):1528-33 PubMed
J Stroke Cerebrovasc Dis. 2016 Oct;25(10):2543-8 PubMed
Stroke. 2012 Nov;43(11):3003-6 PubMed
J Neurol. 2010 Jun;257(6):999-1003 PubMed
Neurocrit Care. 2016 Apr;24(2):172-9 PubMed
Neurology. 2004 Feb 24;62(4):574-80 PubMed
Stroke. 2012 Jan;43(1):240-2 PubMed
Neurology. 2008 Jun 10;70(24 Pt 2):2371-7 PubMed
Int J Stroke. 2015 Dec;10(8):1224-8 PubMed
Stroke. 2013 Jun;44(6):1561-6 PubMed
Stroke. 2011 Sep;42(9):2498-502 PubMed
JAMA. 1995 Oct 4;274(13):1017-25 PubMed
Stroke. 2009 Jan;40(1):140-6 PubMed
Neurocrit Care. 2015 Dec;23(3):394-400 PubMed
Cerebrovasc Dis. 2011;32(4):349-53 PubMed
Stroke. 2008 Dec;39(12):3316-22 PubMed
Front Neurol Neurosci. 2012;30:128-31 PubMed
Ann Neurol. 2013 Jun;73(6):688-94 PubMed
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014 Dec;158(4):528-34 PubMed
Cerebrovasc Dis. 2008;25(5):457-507 PubMed
Am J Epidemiol. 2007 Mar 15;165(6):710-8 PubMed
Arch Neurol. 2005 Jul;62(7):1126-9 PubMed
Intravenous Thrombolysis in Posterior Circulation Stroke